We invite you to attend the 2nd Bugs & Drugs: Antibacterial Drug Discovery Conference, which will take place June 1-2, 2016 in San Diego, CA.
The discovery of penicillin in 1928 was a major success and antibiotics have been used to treat a large number of patients with infectious disease. Over the almost 100 years since Fleming’s discovery of penicillin, the bugs have developed resistance to antibiotics and continue to adapt at an disturbing rate to new and emerging therapies. The increase and spread of antibiotic-resistance and the reduced investment by the pharmaceutical industry have given us an unsettling glimpse of a post-antibiotic era. Ultimately, it is the goal of the scientific community, and certainly that of the attendees, to forestall that event and to prevent the serious consequences that would come inevitably from it.
The 2nd Bugs & Drugs: Antibacterial Drug Discovery conference is designed to bring leaders from academic, pharmaceutical and biotech communities, scientists and clinicians together for 2 days to discuss the development and discovery of new antibiotics, new diagnostics, new targets and non-traditional approaches to tackling multi-drug resistance.
Misuse of Antibiotics: How did we get here? Why are things so bad?
Antibiotic Resistance Threaten the Patients and the Industry
Antimicrobial Stewardship: the need to shift "culture change"
Developing New Antibiotics with Regulatory Support
Developing New Diagnostics
Effects of the Antibiotics on the Mircrobiome
Collaborative Efforts Against Multidrug Resistance
The Next Generation of Approaches of Antibiotics
06月01日
2016
06月02日
2016
摘要截稿日期
注册截止日期
留言